David Hankinson - Avivagen Executive Director
| VIV Stock | CAD 0.01 0.00 0.00% |
Director
Mr. David Hankinson is Executive Director of Avivagen Inc. He is no longer Chief Executive Officer of the Company effective March 11, 2013. He was October 2010 to present Chief Executive Officer, August 2005 to October 2010 Chairman of the Board of the Corporationrationration, Dec 1997 to Aug 2005 Board Chairman at Occell Inc. since 2013.
| Tenure | 11 years |
| Address | 100 Sussex Drive, Ottawa, ON, Canada, K1A 0R6 |
| Phone | 613-702-2908 |
| Web | https://www.avivagen.com |
Avivagen Management Efficiency
The company has return on total asset (ROA) of (1.9344) % which means that it has lost $1.9344 on every $100 spent on assets. This is way below average. Avivagen's management efficiency ratios could be used to measure how well Avivagen manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to climb to 2.28 in 2024, whereas Return On Tangible Assets are likely to drop (4.20) in 2024. At this time, Avivagen's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 148.9 K in 2024, whereas Intangible Assets are likely to drop 347.99 in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Gary Buckley | Exchange Income | 58 | |
| Michel Desbiens | Rogers Sugar | 75 | |
| Gary Collins | Rogers Sugar | 55 | |
| John Angus | Extendicare | N/A | |
| Sandra Hanington | Extendicare | 57 | |
| Edward Warkentin | Exchange Income | 69 | |
| Donna Kingelin | Extendicare | 63 | |
| Samir Manji | Extendicare | 50 | |
| Norma Beauchamp | Extendicare | 57 | |
| Gail Paech | Extendicare | 69 | |
| Jeffrey Olin | Exchange Income | 52 | |
| Dean Bergmame | Rogers Sugar | N/A | |
| Allan Davis | Exchange Income | 62 | |
| Dallas Ross | Rogers Sugar | N/A | |
| Serena Kraayeveld | Exchange Income | 67 | |
| Stuart Belkin | Rogers Sugar | N/A | |
| Donald Streuber | Exchange Income | 61 | |
| Polly Craik | Exchange Income | 57 | |
| Alan Hibben | Extendicare | 65 | |
| Tony Hupman | Chemtrade Logistics Income | N/A | |
| Howard Dean | Extendicare | N/A | |
Management Performance
| Return On Asset | -1.93 |
Avivagen Leadership Team
Elected by the shareholders, the Avivagen's board of directors comprises two types of representatives: Avivagen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avivagen. The board's role is to monitor Avivagen's management team and ensure that shareholders' interests are well served. Avivagen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avivagen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tracy BVSC, Director Manager | ||
| David Hankinson, Executive Director | ||
| Louis Hui, Director - Business Development | ||
| Chris Boland, CFO | ||
| David Allan, Director | ||
| Ira Levy, Interim Officer | ||
| Amin Khalifa, Independent Director | ||
| Aubrey Dan, Director | ||
| Cameron Groome, CEO and President and Director | ||
| Vanessa Grant, Director | ||
| Andrew Basek, Director of Investor Relations | ||
| Drew Basek, Director of Investor Relations | ||
| Paul Mesburis, Lead Director | ||
| James Nickerson, President Innovation | ||
| Graham Burton, Co-Founder, Director of Commercialization Science and Director | ||
| G Anthony, Independent Director |
Avivagen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avivagen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -1.93 | ||||
| Operating Margin | (10.47) % | ||||
| Current Valuation | 7.61 M | ||||
| Shares Outstanding | 77.69 M | ||||
| Shares Owned By Insiders | 1.11 % | ||||
| Number Of Shares Shorted | 6.25 K | ||||
| Price To Earning | (7.32) X | ||||
| Price To Sales | 0.54 X | ||||
| Revenue | 939.17 K | ||||
| Gross Profit | 400.3 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Avivagen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Avivagen Stock analysis
When running Avivagen's price analysis, check to measure Avivagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avivagen is operating at the current time. Most of Avivagen's value examination focuses on studying past and present price action to predict the probability of Avivagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avivagen's price. Additionally, you may evaluate how the addition of Avivagen to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |